The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...